From: The association of nonalcoholic fatty liver disease with bone mineral density in type 2 diabetes
Type 2 diabetes (n = 534) | Non-diabetes (n = 554) | P-value | |
---|---|---|---|
Demographics | |||
Age (years) | 69.5 ± 9.6 | 70.9 ± 9.8 | 0.177 |
Female | 315(58.9) | 343(61.9) | 0.629 |
Height (cm) | 158.3 ± 8.6 | 155.8 ± 9.1 | 0.001* |
Body weight (kg) | 62.2 ± 10.4 | 56.7 ± 11.9 | 0.001* |
BMI (kg/cm2) | 24.8 ± 0.4 | 23.4 ± 0.5 | 0.004* |
Smoking history | 137(25.6) | 115(20.7) | 0.835 |
Drinking history | 114(21.3) | 100(18.1) | 0.706 |
Laboratory data | |||
HbA1c (%) | 8.6 ± 2.3 | 5.6 ± 0.9 | 0.001* |
T-chol (mmol/L) | 4.75 ± 2.5 | 4.47 ± 1.1 | 0.075 |
Triglyceride (mmol/L) | 2.2 ± 1.8 | 1.6 ± 2.5 | 0.165 |
HDL-C (mmol/L) | 1.3 ± 0.3 | 1.4 ± 0.4 | 0.170 |
LDL-C (mmol/L) | 2.6 ± 0.9 | 2.5 ± 1.1 | 0.326 |
ALT (U/l) | 27 ± 26 | 23 ± 14 | 0.027 |
AST (U/l) | 25 ± 19 | 27 ± 13 | 0.565 |
Creatinine (umol/L) | 73 ± 56 | 64 ± 23 | 0.009* |
Uric acid (umol/L) | 292 ± 142 | 315 ± 108 | 0.025* |
Calcium (mmol/L) | 2.3 ± 0.1 | 2.2 ± 0.1 | 0.001* |
BMD | 0.91 ± 0.2 | 0.85 ± 0.2 | 0.025* |
T-Score | − 1.1 ± 1.6 | − 1.5 ± 1.76 | 0.001* |
Z-Score | 0.32 ± 1.3 | 0.25 ± 1.4 | 0.003* |